{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:57:56Z","timestamp":1781326676926,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-INSB-04-01"],"award-info":[{"award-number":["ANR-10-INSB-04-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Foundation of France","doi-asserted-by":"publisher","award":["2023-265613"],"award-info":[{"award-number":["2023-265613"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["2021-239736"],"award-info":[{"award-number":["2021-239736"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["COEN4014"],"award-info":[{"award-number":["COEN4014"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008211","name":"Association France Parkinson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biomaterials.2025.123864","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:53:04Z","timestamp":1763765584000},"page":"123864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Functional targeting of Glypican-4 by a conformation-specific single-domain antibody"],"prefix":"10.1016","volume":"328","author":[{"given":"Remi","family":"Bonjean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5768-4528","authenticated-orcid":false,"given":"Rossana","family":"Cuciniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Kerfelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-9464","authenticated-orcid":false,"given":"Rosanna","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123864_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.cellbio.18.012502.083458","article-title":"Regulatory principles of developmental signaling","volume":"18","author":"Freeman","year":"2002","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.devcel.2011.06.001","article-title":"Extracellular movement of signaling molecules","volume":"21","author":"Muller","year":"2011","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123864_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.tibs.2014.07.008","article-title":"Spatial and temporal organization of signaling pathways","volume":"39","author":"Housden","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123864_bib4","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/jcp.26042","article-title":"The roles of signaling pathways in bone repair and regeneration","volume":"233","author":"Majidinia","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123864_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005975","article-title":"Signaling mechanisms controlling cell fate and embryonic patterning","volume":"4","author":"Perrimon","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123864_bib6","doi-asserted-by":"crossref","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123864_bib7","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-016-2433-5","article-title":"Control of signaling molecule range during developmental patterning","volume":"74","author":"Wilcockson","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123864_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1681","article-title":"Heparan sulphate proteoglycans: the sweet side of development","volume":"6","author":"Hacker","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123864_bib9","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1242\/dev.098178","article-title":"Heparan sulfate proteoglycans: a sugar code for vertebrate development?","volume":"142","author":"Poulain","year":"2015","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123864_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00018-007-7471-6","article-title":"Fine-tuning of cell signaling by glypicans","volume":"68","author":"Fico","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biomaterials.2025.123864_bib11","series-title":"Signalling Mechanisms Underlying Congenital Malformation: The Gatekeepers, Glypicans., Congenital Malformations","author":"Fico","year":"2011"},{"issue":"1657","key":"10.1016\/j.biomaterials.2025.123864_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0545","article-title":"Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis","volume":"369","author":"Matsuo","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123864_bib13","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002493","article-title":"Shaping morphogen gradients by proteoglycans","volume":"1","author":"Yan","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"7542","key":"10.1016\/j.biomaterials.2025.123864_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14259","article-title":"Notum deacylate Wnt proteins to suppress signalling activity","volume":"519","author":"Kakugawa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2025.123864_bib15","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1002\/pgr2.5","article-title":"Glypicans, 35 years later","volume":"1","author":"Filmus","year":"2023","journal-title":"Proteoglycan Res."},{"issue":"20","key":"10.1016\/j.biomaterials.2025.123864_bib16","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1242\/dev.00706","article-title":"Glypican 4 modulates FGF signalling and regulates dorsoventral forebrain patterning in Xenopus embryos","volume":"130","author":"Galli","year":"2003","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2006.10.010","article-title":"Glypican-3: from the mutations of simpson-golabi-behmel genetic syndrome to a tumor marker for hepatocellular carcinoma","volume":"82","author":"Jakubovic","year":"2007","journal-title":"Exp. Mol. Pathol."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123864_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.trecan.2018.09.004","article-title":"Glypicans as cancer therapeutic targets","volume":"4","author":"Li","year":"2018","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1534-5807(01)00005-3","article-title":"The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension","volume":"1","author":"Topczewski","year":"2001","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biomaterials.2025.123864_bib20","first-page":"415","article-title":"Immunotherapy for hepatobiliary cancers: emerging targets and translational advances","author":"Li","year":"2022","journal-title":"Adv. Cancer Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123864_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091339","article-title":"Glypican 3-Targeted therapy in hepatocellular carcinoma","volume":"11","author":"Nishida","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccell.2021.12.005","article-title":"GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity","volume":"40","author":"Heitzeneder","year":"2022","journal-title":"Cancer Cell"},{"issue":"32","key":"10.1016\/j.biomaterials.2025.123864_bib23","doi-asserted-by":"crossref","first-page":"E6623","DOI":"10.1073\/pnas.1706055114","article-title":"Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123864_bib24","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4103\/1673-5374.165274","article-title":"Glypican 4 down-regulation in pluripotent stem cells as a potential strategy to improve differentiation and to impair tumorigenicity of cell transplants","volume":"10","author":"Dono","year":"2015","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123864_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/sctm.20-0177","article-title":"Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation","volume":"10","author":"Corti","year":"2021","journal-title":"Stem Cells Transl. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123864_bib26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/stem.1165","article-title":"Modulating Glypican4 suppresses tumorigenicity of embryonic stem cells while preserving self-renewal and pluripotency","volume":"30","author":"Fico","year":"2012","journal-title":"Stem Cell."},{"issue":"24","key":"10.1016\/j.biomaterials.2025.123864_bib27","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1523\/JNEUROSCI.2501-13.2014","article-title":"Reducing Glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation","volume":"34","author":"Fico","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41467-023-35965-8","article-title":"Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-beta protein sensing","volume":"14","author":"Legier","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib29","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1038\/s41467-019-11662-3","article-title":"CD36 inhibits beta-catenin\/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis","volume":"10","author":"Fang","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123864_bib30","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1002\/jcb.27266","article-title":"Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt\/beta-catenin pathway in pancreatic cancer cells","volume":"119","author":"Cao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2025.123864_bib31","article-title":"Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure","volume":"121\u2013122","author":"Muendlein","year":"2023","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.biomaterials.2025.123864_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1045995","article-title":"Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients","volume":"12","author":"Muendlein","year":"2022","journal-title":"Front. Oncol."},{"issue":"34","key":"10.1016\/j.biomaterials.2025.123864_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108870119","article-title":"Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation","volume":"119","author":"Saroja","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib34","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/s41598-024-54800-8","article-title":"Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease","volume":"14","author":"Tatenhorst","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123864_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/jdi.12071","article-title":"Glypican-4 is a new comer of adipokines working as insulin sensitizer","volume":"4","author":"Tamori","year":"2013","journal-title":"J. Diabete. Investig."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123864_bib36","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2012-4297","article-title":"Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease","volume":"98","author":"Yoo","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/19420862.2018.1556465","article-title":"Antibodies to watch in 2019","volume":"11","author":"Kaplon","year":"2019","journal-title":"mAbs"},{"issue":"6428","key":"10.1016\/j.biomaterials.2025.123864_bib38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123864_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/08830185.2018.1526932","article-title":"Single-domain antibodies or nanobodies: a class of next-generation antibodies","volume":"37","author":"Khodabakhsh","year":"2018","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2025.123864_bib40","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123864_bib41","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies","volume":"103","author":"De Genst","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.biomaterials.2025.123864_bib42","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261395","article-title":"30 years of nanobodies - an ongoing success story of small binders in biological research","volume":"136","author":"Frecot","year":"2023","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2025.123864_bib43","doi-asserted-by":"crossref","first-page":"E1083","DOI":"10.1073\/pnas.1217868110","article-title":"Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma","volume":"110","author":"Feng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.stemcr.2017.04.022","article-title":"Expansion and purification are critical for the therapeutic application of pluripotent stem cell-derived myogenic progenitors","volume":"9","author":"Kim","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"14","key":"10.1016\/j.biomaterials.2025.123864_bib45","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1111\/j.1742-4658.2009.07101.x","article-title":"Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen","volume":"276","author":"Behar","year":"2009","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1074\/mcp.O112.025486","article-title":"Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display","volume":"13","author":"Even-Desrumeaux","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123864_bib47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biomaterials.2025.123864_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baad021","article-title":"NbThermo: a new thermostability database for nanobodies","volume":"2023","author":"Valdes-Tresanco","year":"2023","journal-title":"Database"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","article-title":"Cell-cell communication: new insights and clinical implications","volume":"9","author":"Su","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/a-1257-0774","article-title":"How reliable are commercially available Glypican4 ELISA kits?","volume":"130","author":"Buhl","year":"2022","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"35","key":"10.1016\/j.biomaterials.2025.123864_bib51","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.0805862105","article-title":"Surfen, a small molecule antagonist of heparan sulfate","volume":"105","author":"Schuksz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123864_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neuron.2017.09.053","article-title":"Astrocyte-secreted glypican 4 regulates release of neuronal pentraxin 1 from axons to induce functional synapse formation","volume":"96","author":"Farhy-Tselnicker","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.biomaterials.2025.123864_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.732429","article-title":"Glypican 4 regulates abeta internalization in neural stem cells partly via low-density lipoprotein receptor-related protein 1","volume":"15","author":"Ma","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123864_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jovcevska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.biomaterials.2025.123864_bib55","series-title":"Antibody Engineering Volume 2","author":"Kontermann","year":"2014"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225007847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:39:21Z","timestamp":1781325561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225007847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S0142961225007847"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123864","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional targeting of Glypican-4 by a conformation-specific single-domain antibody","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123864"}}